Sanofi, GSK to supply 60 million doses of COVID-19 vaccine to UK
Pharma majors Sanofi and GlaxoSmithKline (GSK) have reached an agreement with the UK government for supplying up to 60 million doses of their jointly developed COVID-19 vaccine candidate. The agreement will be subject to a final contract issued by the British government. The COVID-19 vaccine candidate has been developed by Sanofi in partnership with British […]
Mylan and Biocon have secured approval from the US Food and Drug Administration (FDA) for Semglee (insulin glargine injection) in vial and pre-filled pen presentations to regulate high blood sugar in adults with type 2 diabetes and adult and pediatric patients with type 1 diabetes. According to Mylan, Semglee has an identical amino acid sequence […]
Continue reading …
Regeneron Pharmaceuticals and Sanofi said that their co-developed eczema drug Dupixent (dupilumab) has met the co-primary endpoints of Part A of a phase 3 trial in patients 12 years and older who have eosinophilic esophagitis (EoE). The late-stage trial also all the key secondary endpoints. Dupixent is now the first and only biologic to demonstrate […]
Continue reading …
French pharma company Sanofi has announced a COVID-19 vaccine partnership with GlaxoSmithKline (GSK) to develop an adjuvanted vaccine for the novel coranavirus, by combining their drug discovery technologies. Sanofi will provide its S-protein Covid-19 antigen based on recombinant DNA technology to the partnership. The technology is said to be used for generating an exact genetic […]
Continue reading …
Baxter International, a US-based health care company, has signed a deal worth $350 million to acquire Seprafilm Adhesion Barrier and related assets from French pharma company Sanofi, in a move to expand its advanced surgery portfolio. Seprafilm Adhesion Barrier is a medical device, which has FDA approval for preventing adhesion in patients going through abdominal […]
Continue reading …
Libtayo EMA approval : The European Commission has given conditional approval for Libtayo (cemiplimab) for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC), which is one of the most commonly diagnosed skin cancers. Libtayo, which is a fully-human monoclonal antibody targeting the immune checkpoint receptor programmed cell death […]
Continue reading …Praluent bags EC approval to reduce risk of CV events in patients with ASCD
March 24, 2019 No Comment
Regeneron Pharmaceuticals and Sanofi have secured approval for Praluent (alirocumab) for a new indication from the European Commission (EC), which is for the reduction of cardiovascular risk in adults with established atherosclerotic CV disease (ASCD) by reducing low-density lipoprotein cholesterol (LDL-C) levels as an adjunct to correct other risk factors. Atherosclerotic CV Disease is defined […]
Continue reading …
Cablivi FDA approval : Belgian biopharma company Ablynx has bagged approval from the US Food and Drug Administration (FDA) for its anti-vWF nanobody Cablivi (caplacizumab-yhdp) injection in combination with plasma exchange and immunosuppressive therapy for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP). According to the FDA, aTTP is a rare blood clotting disorder in […]
Continue reading …
Dupixent FDA approval : Dupixent (dupilumab), an eczema drug the co-developed by Sanofi and Regeneron Pharmaceuticals, has been approved by the US Food and Drug Administration as an add-on maintenance therapy for two forms of asthma. Dupixent FDA Approval The new Dupixent FDA approval is for treating patients with moderate-to-severe asthma aged 12 years and older […]
Continue reading …
Dupixent (dupilumab), the co-developed eczema injection from pharma giants Sanofi and Regeneron Pharmaceuticals, has got the US FDA approval for the treatment of moderate-to-severe atopic dermatitis (AD) in adult patients. Dupixent eczema injection with that has become the first ever biologic medicine approved for atopic dermatitis treatment in patients whose disease is not managed adequately […]
Continue reading …
Business News Today
- Apollo to invest $265m in Maryland offshore wind project owner US Wind
- Liberty Steel Group to acquire Hayange and Ascoval steel plants in France
- TEMCO smelter in Tasmania to be acquired by Sanjeev Gupta’s GFG Alliance
- AGC Networks acquires communications technology firm Pyrios
- Manna Pro Products acquires online pet brand Doggie Dailies
- MedCrypt acquires medical device cybersecurity software firm MedISAO
- Improving acquires custom software development firm Object Partners
- High Street Insurance acquires Michigan-based Capital Insurance Group
- US department store chain Stein Mart files for bankruptcy protection
- Mill Creek Residential breaks ground on Modera Washington in Houston
